XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2021
Stock-Based Compensation [Abstract]  
Stock-Based Compensation 4.           Stock-Based Compensation

During the six-month period ended June 30, 2021, 1,000 stock options were granted at a price of $26.35 per share. As of June 30, 2021, there was $107,000 of total unrecognized compensation cost related to non-vested options granted in 2020 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2021. Compensation costs related to stock options amounted to $107,000 and $102,000 during the six-month periods ended June 30, 2021 and 2020, respectively.

A summary of the Company’s stock option activity for the six-month period ended June 30, 2021 is as follows:

Weighted

Average Exercise

Weighted Average

Aggregate

Price

Remaining

Intrinsic Value

Options

Per Share

Contractual Term

($000)

Outstanding at January 1, 2021

215,970

$

25.73

6.0

Yrs.

$

743

Granted

1,000

26.35

10.0

Exercised

(8,970)

18.91

2.4

Forfeited

(2,250)

33.72

7.7

Outstanding at June 30, 2021

205,750

$

25.94

5.7

Yrs.

$

662

Exercisable at June 30, 2021

171,000

$

25.75

4.9

Yrs.

$

662

Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $26.00 per share as of June 30, 2021 and $26.17 per share as of December 31, 2020.

A summary of the Company’s restricted stock activity for the six-month periods ended June 30, 2021 and 2020 is as follows:

2021

2020

Weighted-Average

Weighted-Average

Number of

Grant Date

Number of

Grant Date

Restricted Stock

Fair Value

Restricted Stock

Fair Value

Non-vested, January 1,

39,135

$

30.72

36,195

$

36.23

Granted

Vested

Forfeited

(3,900)

30.86

Non-vested, June 30,

35,235

$

30.71

36,195

$

36.23

The expected future compensation expense relating to the 35,235 shares of non-vested restricted stock outstanding as of June 30, 2021 is $914,000. This cost will be recognized over the remaining vesting period of 4.5 years. Compensation costs related to restricted stock amounted to $167,000 and $167,000 during the six-month periods ended June 30, 2021 and 2020, respectively.